Welcome to LookChem.com Sign In|Join Free

CAS

  • or

150840-27-0

6-{[(3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino}hexanoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

150840-27-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 150840-27-0 Structure

  • Basic information

    1. Product Name: 6-{[(3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino}hexanoic acid
    2. Synonyms:
    3. CAS NO:150840-27-0
    4. Molecular Formula: C36H59NO4
    5. Molecular Weight: 569.858
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 150840-27-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 695.7°C at 760 mmHg
    3. Flash Point: 374.6°C
    4. Appearance: N/A
    5. Density: 1.067g/cm3
    6. Vapor Pressure: 2.17E-22mmHg at 25°C
    7. Refractive Index: 1.528
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 6-{[(3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino}hexanoic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: 6-{[(3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino}hexanoic acid(150840-27-0)
    12. EPA Substance Registry System: 6-{[(3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino}hexanoic acid(150840-27-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 150840-27-0(Hazardous Substances Data)

150840-27-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 150840-27-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,8,4 and 0 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 150840-27:
(8*1)+(7*5)+(6*0)+(5*8)+(4*4)+(3*0)+(2*2)+(1*7)=110
110 % 10 = 0
So 150840-27-0 is a valid CAS Registry Number.

150840-27-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carbonyl]amino]hexanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:150840-27-0 SDS

150840-27-0Downstream Products

150840-27-0Relevant articles and documents

Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors

Dang, Zhao,Lai, Weihong,Qian, Keduo,Ho, Phong,Lee, Kuo-Hsiung,Chen, Chin-Ho,Huang, Li

experimental part, p. 7887 - 7891 (2010/04/30)

Wepreviously reported that [[N-[3β-hydroxyllup-20(29)-en-28-oyl]-7- aminoheptyl]carbamoyl]methane (A43D, 4) was a potent HIV-1 entry inhibitor. However, 4 was inactive against HIV-2 virus, suggesting the structural requirements for targeting these two ret

Betulinic acid derivatives: A new class of specific inhibitors of human immunodeficiency virus type 1 entry

Soler, Fran?oise,Poujade, Christèle,Evers, Michel,Carry, Jean-Christophe,Hénin, Yvette,Bousseau, Anne,Huet, Thierry,Pauwels, Rudi,De Clercq, Erik,Mayaux, Jean-Fran?ois,Le Pecq, Jean-Bernard,Dereu, Norbert

, p. 1069 - 1083 (2007/10/03)

A novel series of ω-aminoalkanoic acid derivatives of betulinic acid were synthesized and evaluated for their activity against human immunodeficiency virus (HIV). The anti-HIV-1 activity of several members of this new series was found to be in the nanomolar range in CEM 4 and MT-4 cell cultures. The optimization of the ω-aminoalkanoic acid side chain is described. The presence of an amide function within the side chain was found important for optimal activity. RPR 103611 (14g), a statine derivative, was found to be inactive against HIV-1 protease, reverse transcriptase, and integrase as well as on gp120/CD4 binding. 'Time of addition' experiments suggested interaction with an early step of HIV-1 replication. As syncytium formation, but not virus-cell binding, seems to be affected, betulinic acid derivatives are assumed to interact with the postbinding virus-cell fusion process.

Lupane derivatives, their preparation and the pharmaceutical compositions which contain them

-

, (2008/06/13)

The present invention relates to new lupane dervivatives of the general formula: STR1 to their salts, to their preparation and to the pharmaceutical compositions which contain them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 150840-27-0